Ctgf antibody clinical

WebConnective tissue growth factor (CTGF), also termed fisp12, β IG-M2, and IGF-BP8, is a secreted cysteine-rich growth factor that belongs to the CCN (cyr61, CTGF, nov) family. … WebJan 12, 2011 · San Francisco, CA - January 12, 2011. FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung …

CTGF is a central mediator of tissue remodeling and …

WebFG-3019 is a fully human monoclonal antibody specific for CTGF. Pre-clinical studies suggest that FG-3019 penetrates into tissues to reduce effective tissue levels of CTGF … WebCTGF and human anti-human antibodies (HAHA) levels. Plasma was obtained for pharmacokinetic (PK) analyses pre- and post FG-3019 infusions. FG-3019 exposure and plasma CTGF at baseline were correlated with clinical progression and survival outcomes. Assessments of CTGF were limited to baseline values, since subsequent billy\u0027s seafood tierra verde https://kozayalitim.com

CTGF Antibody (E-5) SCBT - Santa Cruz Biotechnology

WebJun 22, 2006 · FG-3019 is an investigational fully human monoclonal antibody against CTGF. In a phase 1 study of FG-3019 in patients with idiopathic pulmonary fibrosis, FG-3019 was found safe and well tolerated. Currently, FG-3019 is the subject of a phase 1b study in diabetic patients with incipient nephropathy. WebMonoclonal Antibody for studying CTGF. Cited in 36 publications. Validated for Western Blotting, Immunofluorescence (Immunocytochemistry). Highly specific and rigorously validated in-house, CTGF (D8Z8U) Rabbit … WebApr 13, 2024 · The identification of tissue-specific promoters for gene therapeutic constructs is one of the aims of complex tumor therapy. The genes encoding the fibroblast activation protein (FAP) and the connective tissue growth factor (CTGF) can function in tumor-associated stromal cells but are practically inactive in normal adult cells. Accordingly, the … cynthia howell alpha kappa alpha

CTGF is a central mediator of tissue remodeling and fibrosis ... - PubMed

Category:CTGF Rabbit pAb-Polyclonal Antibodies - ABclonal

Tags:Ctgf antibody clinical

Ctgf antibody clinical

Efficiency of Promoters of Human Genes FAP and CTGF at …

WebAug 7, 2024 · Pamrevlumab, a fully-human monoclonal antibody that inhibits the activity of connective tissue growth factor (CTGF), is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), pancreatic cancer, and Duchenne muscular dystrophy (DMD). FibroGen is also developing a biosynthetic cornea in China. WebJun 6, 2012 · A monoclonal antibody to CTGF that is currently in clinical development (FG-3019) has demonstrated the ability to reverse vascular stiffening and improve cardiac function in a rat model of diabetic complications. FG-3019 has also exhibited activity in a murine radiation-induced pulmonary fibrosis model.

Ctgf antibody clinical

Did you know?

WebCtgf Antibody, Anti-CTGF antibody produced in rabbit. Tested Applications: immunohistochemistry 1:20- 1:50, immunofluorescence 1-4μg/mL, immunoblotting None. … WebClinical Trials Information. Find NCI-Supported Clinical Trials; What Are Clinical Trials? Paying for Clinical Trials; Patient Safety; Deciding to Take Part in a Trial; Questions to …

Purpose: Pancreatic ductal adenocarcinomas exhibit a high degree … WebInhibiting CTGF with antisense oligonucleotides, small interfering RNA, or neutralizing antibodies has been reported to reduce fibrosis in experimental models of kidney disease (Lee et al., 2015). The results of a phase I trial of FG-3019, an anti-CTGF antibody, demonstrated that this agent reduced albuminuria in patients with diabetic nephropathy.

WebTreatment with an anti-CTGF monoclonal antibody, FG-3019, significantly prolonged survival of mice injected with primary xenograft B-ALL cells when co-treated with conventional chemotherapy (vincristine, L-asparaginase and dexamethasone). Data suggest that CTGF represents a targetable molecular aberration in B-ALL, and blocking CTGF … WebPamrevlumab (anti-CTGF) Catalog No.A2042 For research use only. Not for use in humans. Pamrevlumab, a recombinant human antibody that binds to connective tissue growth factor (CTGF) has emerged as a potential therapy for idiopathic pulmonary fibrosis (IPF).

WebJan 8, 2024 · NIS793 is a monoclonal antibody blocking TGFβ1 and TGFβ2 and is being tested in combination with the anti-PD1 antibody PDR001 in a phase 1 clinical trial of patients with advanced malignancies ...

WebAug 24, 2024 · CTGF, a protein localized in the extracellular matrix, is a driver of fibrotic tissue remodeling as a consequence of an aberrant wound healing process. cynthia howeyWebApr 11, 2024 · Nevertheless, clinical observations have shown that CTGF expression in the sera and fibrotic liver tissues of CHB patients is upregulated. A strong correlation between CTGF with liver fibrosis has also been reported . HBX can induce CTGF expression and secretion in hepatocytes to stimulate HSC activation . Multiple regulatory mechanisms ... cynthia howe massachusettsWebMar 22, 2024 · CTGF Antibody (E-5) is an IgG 2a κ mouse monoclonal CTGF antibody (also designated CCN2 antibody or IGFBP-8 antibody) that detects the CTGF protein of mouse, rat and human origin by WB, IP, IF and ELISA. CTGF Antibody (E-5) is available as both the non-conjugated anti-CTGF antibody form, as well as multiple conjugated forms … cynthia howes grace cottageWebOct 14, 2014 · Clinical trials of anti-CTGF antibodies in idiopathic pulmonary fibrosis and pancreatic cancer have been initiated. 51,52,53,54,55,56. In cardiovascular models, the role of CTGF is still highly ... cynthia howe obituaryWebJun 22, 2006 · FibroGen, Inc., today announced the publication of two studies demonstrating that connective tissue growth factor (CTGF) plays a causative role in pancreatic cancer … billy\u0027s shoe repairWebPamrevlumab is a potential first-in-class antibody being developed by FibroGen to inhibit the activity of connective tissue growth factor (CTGF), a common factor in fibrotic and … cynthia howellWebPamrevlumab is in Phase 3 clinical studies for the treatment of idiopathic pulmonary fibrosis, Duchenne muscular dystrophy, and locally advanced pancreatic cancer. … billy\\u0027s seamless gutters piqua ohio